Shaping Tomorrow's Healthcare: How Al is Changing Health Industry

Thursday, March 21, 2024
12:00 pm to 1:30 pm EDT
Via Zoom

Register now ›


About the Summit

View details Hide details

Dean Detlev Zwick of the Schulich School of Business and Joseph Mapa, Krembil Chair in Health Management and Leadership invite you to our sixth virtual healthcare leadership summit.

The future of Al promises significant transformative changes for healthcare. As the proliferation of Al spreads across the sector, it’s important to keep up to date on emerging innovations and applications in the workplace. Join industry leaders for a discourse on how Al is changing clinical and operational decision making and driving pioneering drug discovery, with insights into some of the most significant emerging AI solutions.


View details Hide details


12:00 pm: Introductions

12:10 pm: Keynote Presentations

    • Clinical Perspective: Dr. Barry Rubin, Professor of Surgery, University of Toronto, Program Medical Director, Peter Munk Cardiac Centre
    • Operational Perspective: Professor Agni Orfanoudaki, Associate Professor of Operations Management, Saïd Business School, University of Oxford
    • Pharmaceutical Perspective: Mr. Alok Kanti, President, Apotex International
    • Investor Perspective: Ms. Sanjana Basu, Investor, Radical Ventures

12:50 pm: Fireside Chat with Speakers

1:15 pm: Audience Q&A

1:25 pm: Closing

Host Host

Joseph Mapa

Centre Director
Krembil Chair in Health Management and Leadership
Executive Director, Health Industry Management Program
Adjunct Professor, Schulich School of Business

After serving as President and CEO of Mount Sinai Hospital in Toronto for 14 years and then 2 more years as Founding President and CEO of Sinai Health, (a multi-organization, integrated healthcare system) – Joseph Mapa assumed the role of Executive Director of the Health Industry Management Program (MBA specialization) at the Schulich School of Business, York University. In 2021, he was also appointed as inaugural Director of the Krembil Centre for Health Management and Leadership. An Adjunct Professor, he teaches on high performance leadership and strategic positioning in the health care sector. He holds an MBA from the Rotman School of Management, University of Toronto and is a Fellow of both the Canadian College of Health Leaders and the American College of Healthcare Executives. Most recently, during the Covid-19 pandemic, he served as Executive Advisor to the Board of Sienna Seniors Living Inc. ( a publicly traded company of long term care communities and retirement residences); he served on the Advisory Board of MyRemoteClinic (a start-up company providing digital platforms to health and wellness practitioners); and is a Special Advisor to the Board of Canadian Friends of Herzog Hospital in Jerusalem. He also served on numerous sector organizations including Past Chair of the Council of Academic Hospitals of Ontario and Past Co-Chair of Toronto Academic Health Science Network. He also served as Vice Chair of the Canadian College of Health Leaders. He has completed terms on the Governing Council of the University of Toronto; the Ontario Hospital Association Board; the Board of the Canadian Nurses Association; the Advisory Board of the Women’s Executive Network – Canada’s Most Powerful Women Top 100; and on the Board of Governors of Canada’s “10 Most Admired Corporate Cultures”. Joseph is co-author and/or co-editor of numerous articles and books focusing on healthcare management – including a publication on effective government relations in the health care industry. He has been honoured for his leadership and academic contributions with numerous recognitions including the Chairman’s Award for Distinguished Service and the Mentorship Award by the Canadian College of Health Leaders. A recipient of the Teaching Excellence Award at the Schulich School of Business, Joseph was also highlighted in a feature by Financial Post Magazine on “some of the notable graduates from internationally ranked MBA schools in Canada.” in the health care sector.



Moderator Moderator

Dr. Abi Sriharan

Scientific Director, Krembil Centre for Health Management and Leadership

Dr. Abi Sriharan is a senior scientist and research director at the Krembil Centre for Health Management and Leadership at the Schulich School of Business at York University, Canada.

She is an internationally recognized authority on systems leadership and innovation. Her current research focuses on three streams of work: the impact of digital innovations on the workforce, the future of work in the health sector, and the presence of women in the workforce. Popular media outlets have covered her work, including the The Globe and Mail, the Toronto Star, CTV News, and Global TV. She has received awards for her research from the Global Alliance for Medical Education, the Vice-Chancellor’s Award for Civic Engagement from the University of Oxford, and the President’s Award from the Alliance for Continuing Education in the Health Professions. In 2022, she was named a Connaught Global Scholar for her research on AI and the future of work in the health sector.

Dr. Sriharan teaches executive and graduate programs on human factors and innovation strategies. From 2018 to 2023, Dr. Sriharan served as the program director of the Master in System Leadership and Innovation (MSc SLI) program at the University of Toronto and led its curriculum transformation. The MSc SLI program is widely considered Canada’s first graduate program to train physicians on systems leadership and innovation. In recognition of her academic leadership, in 2021, she received the Eugene Stuart Program Leadership Award from the University of Toronto.

Dr. Sriharan is a professionally certified leadership coach with the International Coaches Federation and a Fellow of the Institute of Coaching at Harvard University. She regularly coaches high-performance physicians and senior health-care executives.

Before her academic career, Dr. Sriharan spent ten years as senior health-care executive and consultant for organizations in Canada and the United States, advising the management teams of multinational health-sector organizations in over fifteen countries on health systems innovation and transformation.

Dr. Sriharan received her DPhil and MSc from the University of Oxford and her bachelor’s degree from the University of Toronto. She received additional leadership training from Harvard University and the Weatherhead School of Management at Case Western Reserve University.


Keynote Speakers

View details Hide details
Dr. Barry Rubin Dr. Barry Rubin


Dr. Barry Rubin
Professor of Surgery, University of Toronto
Program Medical Director, Peter Munk Cardiac Centre

Dr. Rubin completed an undergraduate degree in physics and physiology and medical school at McGill University. After a PhD in Experimental Medicine, he finished General and Vascular Surgery training in Toronto, and joined the surgical faculty at University Health Network (UHN) in 1995. Dr. Rubin holds the rank of Professor of Surgery at the University of Toronto.

Dr. Rubin was Head of the Division of Vascular Surgery at UHN, and is currently the Medical Director of the Peter Munk Cardiac Centre.

Dr. Rubin’s basic science research laboratory was continuously funded by the Canadian Institutes of Health Research for 19 years. His research focused on the way the heart responds to injury and the regulation of the immune response to infection. More recently, he led research into the drivers of clinician burnout at UHN. Dr. Rubin is co-Chair of the US National Academy of Medicine Clinician Wellbeing Implementation Working Group, and is a member of the steering committee led by Vivek Murthy, US Surgeon General and Victor Dzau, President of the National Academy of Medicine that published the US National Plan for Health Workforce Wellbeing. Dr. Rubin has been retained by the Royal College of Physicians and Surgeons of Canada to help develop a Canadian National Plan for Health Workforce Wellbeing. Dr. Rubin also led development of the Peter Munk Cardiac Centre AI Team.

Dr. Rubin is the elected lead for 17 Academic Health Science Centres in Ontario that include 8,000 academic physicians for the management of the $275,000,000 per annum Academic Physicians Alternative Funding Plan, which is designed to retain physicians at Academic Health Science Centres and support teaching, research and innovation. He co-led Epic implementation at UHN, and was the inaugural Chair of the Ontario New Technologies Planning Committee, which advises the Government of Ontario in regard to funding for new devices used in the management of patients with Vascular or Cardiac disease, or Stroke.

Professor Agni Orfanoudaki Professor Agni Orfanoudaki


Professor Agni Orfanoudaki
Associate Professor of Operations Management, Saïd Business School, University of Oxford

Agni Orfanoudaki is an Associate Professor of Operations Management at the Saïd Business School of Oxford University. Alongside her role, Agni is a Management Studies Fellow at Exeter College and a visiting scholar at the Harvard Kennedy School as a Harvard Data Science Initiative Fellow. She leads the Data-Driven Decisions Lab (3DL) at Oxford, conducting theoretical and empirical research with machine learning, optimisation, and stochastic processes. Using datasets from industry and academic partners, and guided by conversations with practitioners, the members of 3DL focus on proposing new methodologies and quantitative frameworks in multiple application areas. These range from healthcare to revenue management and infrastructure. Prior to joining Oxford, Agni received a PhD in Operations Research from the Massachusetts Institute of Technology. She has collaborated with numerous institutions, including a major medical society, two international reinsurance companies, and more than eight hospitals in the US and Europe.
Mr. Alok Kanti Mr. Alok Kanti


Mr. Alok Kanti
President, Apotex International

Alok Kanti is currently the President – International of Apotex. Apotex is a Canadian based global health company currently owned by SK Capital a private equity firm. Apotex employs over 7000 people wordwide and is headquartered in Toronto.

Prior to this role, Alok was President & CEO of Bayer Inc. in Canada from August 2015 to August 2023. He lead the pharmaceuticals business and had oversight for all Bayer divisions. Bayer earns revenues of $2.2 billion annually and employs over 1,200 people across Canada.

Since joining Bayer in 1994, Alok has gained a diverse wealth of experience across geographies and in operational, strategy and product development roles. He has held P&L responsibilities across Bayer’s Pharmaceutical, Animal Health, Diagnostic and Consumer Care divisions. He has managed organizations in over 27 countries, including USA, China, Japan, Russia, Europe, India, Brazil and Australia and New Zealand. He has also helped set up businesses in developing economies such as Cambodia, Myanmar and Vietnam. Prior to his appointment in Canada, Alok was Managing Director of Bayer Healthcare China, where he built the organization to a leading position in the world’s third-largest healthcare market and grew annual revenues to $2.4 billion with over 5,000 employees. In China he was also on the Global Executive Committee of Bayer Pharmaceuticals.

During his tenure in Canada, Bayer Pharma more than doubled its revenue over six years and has been awarded Best Employer and Canada’s most admired Corporate Culture by various organizations.

In addition to his role at Bayer, Alok served as the Chair of the Board at Innovative Medicines Canada, the national association representing Canada’s innovative pharmaceutical industry. Alok is on the Board of Governors of Guelph University, an Advisory Board member of Krembil Centre for Health Management and Leadership at Schulich School of Business, and an Executive in Residence at Rothman School of Management at the University of Toronto.

In October 2019, Alok was inducted into the Canadian Healthcare Marketing Hall of Fame, by the National Pharmaceutical Congress for his passion and commitment to patients, stakeholders and the Canadian healthcare industry.

Alok obtained his Bachelor of Science degree in Civil Engineering from University of Delhi in 1989 and his Master’s in Business Management from the Asian Institute of Management in Manila in 1994, where he was an Asian Development Bank Scholar. He also went on an exchange program at the Marshal School of Business, University of Southern California in Los Angeles. He completed the ICD-Rotman Directors Education Program at the University of Toronto. He is married and has two children. He is fluent in Hindi, English and German. He enjoys yoga, cycling and travelling with this family.

Ms. Sanjana Basu Ms. Sanjana Basu


Ms. Sanjana Basu
Investor, Radical Ventures

Sanjana Basu is an Investor at Radical Ventures. Sanjana believes in the deeply disruptive power of AI to create value across sectors and likes to back technically differentiated teams building AI businesses across verticals. Her investments include Nabla Bio, Orbital Materials, PocketHealth, Signal 1, Synex, Lisa Health, and Ubenwa.
Before joining Radical, Sanjana was an investor in deep tech, consumer tech, and fintech at the Venture arm of the Tata Group in India. Before that, she was an investment banker at Barclays.
Born and raised in Mumbai, India, she completed her MBA from the Indian Institute of Management, Bangalore (IIM-B), and her undergraduate in Economics & International Relations from Tufts University in Boston, US.

Please register your attendance below.


Krembil Centre Logo